Improvement in NAFLD may lead to improvement of metabolic syndrome, cardiovascular disease, and malignancy and vice versa.
Evaluation of Interventions by Clinical Pharmacy Specialists in Cardiology at a VA Ambulatory Cardiology Clinic
Integration of CPSs into an ambulatory cardiology clinic may translate to cost avoidance and a reduction in workload burden for other cardiology...
NIH-funded study highlights new information on the risk of peripheral artery disease among African Americans.
Listen in to the latest Cardiocast for the week’s top news.
CHICAGO – Even in a recent era of antiretroviral therapy, U.S. people with HIV had a higher incidence of cardiovascular disease events.
VA researchers have identified 3 genetic mutations that govern cholesterol levels, which could lead to new drugs to treat cardiovascular disease...
A gene mutation that slows sugar metabolism in the gut may lower risk of diabetes, obesity, heart failure, and even death.
CHICAGO – “Everyone can dramatically improve their health just by moving – anytime, anywhere, and by any means that gets you active.” – Adm. Brett...
CHICAGO – In-hospital initiation of sacubitril/valsartan safely and significantly reduced heart failure rehospitalizations in the next 8 weeks.
Pharmacist Interventions to Reduce Modifiable Bleeding Risk Factors Using HAS-BLED in Patients Taking Warfarin
Use of risk scores and pharmacist follow-up could reduce bleeding risk in patients on anticoagulation therapy.